KSR1 and melanoma: In melanoma harboring the oncogenic BRAFV600E mutation, KSR1 knockout impaired cell proliferation, induced cell cycle arrest, and promoted apoptosis, highlighting a context-dependent synthetic vulnerability in BRAF-driven tumors [83].